Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Satisfem Bud is a nonhormonal over-the-counter vulvar moisturizer developed by FemmePharma for menopausal vulvovaginal symptoms, particularly vulvar dryness, itching, and burning. It is a topical hydrating product delivered via a single-use swab applicator for portable, discreet application. Based on the provided information, it is best characterized as a topical moisturizer and self-care product rather than a pharmaceutical agent with a defined active pharmaceutical ingredient, molecular target, or receptor-mediated mechanism of action. Its intended use is symptomatic relief of menopausal vulvar discomfort, either alone or alongside other FemmePharma menopausal health products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Satisfem Bud.